HARTFORD HOSPITAL
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1998-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- https://hhchealth.org
THC + CBD and Memory Study
Early Phase 1
Not yet recruiting
- Conditions
- Cannabis UseMarijuana UseCannabis Intoxication
- Interventions
- First Posted Date
- 2021-04-22
- Last Posted Date
- 2025-03-25
- Lead Sponsor
- Hartford Hospital
- Target Recruit Count
- 9
- Registration Number
- NCT04855526
Target ADHD Executive Working Memory Study
Not Applicable
Completed
- Conditions
- ADHD
- Interventions
- Behavioral: Placebo TrainingBehavioral: EWM Training
- First Posted Date
- 2021-03-12
- Last Posted Date
- 2023-08-02
- Lead Sponsor
- Hartford Hospital
- Target Recruit Count
- 62
- Registration Number
- NCT04795674
- Locations
- 🇺🇸
Institute of Living/Hartford Hospital, Hartford, Connecticut, United States
Acute Changes In Thermal Pain Response Following Single Oral Dose of Beta-Cary
Phase 1
Withdrawn
- Conditions
- Beta-Caryophyllene
- Interventions
- First Posted Date
- 2021-03-11
- Last Posted Date
- 2021-11-02
- Lead Sponsor
- Hartford Hospital
- Registration Number
- NCT04794205
- Locations
- 🇺🇸
Hartford Hospital, Hartford, Connecticut, United States
Hippocampal Response to Acute Oral Doses of CBD During an fMRI Memory Task
- First Posted Date
- 2021-03-03
- Last Posted Date
- 2024-04-12
- Lead Sponsor
- Hartford Hospital
- Target Recruit Count
- 20
- Registration Number
- NCT04778644
- Locations
- 🇺🇸
Hartford Hospital, Hartford, Connecticut, United States
Inpatient Cognitive-Behavioral Therapy to Reduce Suicide Risk Post-Discharge
Not Applicable
Completed
- Conditions
- Suicide, Attempted
- Interventions
- Behavioral: Cognitive Behavioral Therapy
- First Posted Date
- 2019-11-19
- Last Posted Date
- 2025-04-16
- Lead Sponsor
- Hartford Hospital
- Target Recruit Count
- 213
- Registration Number
- NCT04168645
- Locations
- 🇺🇸
Institute of Living/Hartford Hospital, Hartford, Connecticut, United States
Imipenem-Relebactam Pharmacokinetics in Augmented Renal Clearance
Phase 1
Completed
- Conditions
- Sepsis
- Interventions
- Drug: Imipenem-relebactam
- First Posted Date
- 2019-11-01
- Last Posted Date
- 2024-08-06
- Lead Sponsor
- Hartford Hospital
- Target Recruit Count
- 9
- Registration Number
- NCT04147221
- Locations
- 🇺🇸
Hartford Hospital, Hartford, Connecticut, United States
Omadacycline Tissue Penetration in Diabetic Patients With Wound Infections and Healthy Volunteers Via In Vivo Microdialysis
Phase 1
Completed
- Conditions
- DiabetesWound InfectionHealthy Volunteers
- Interventions
- Procedure: Microdialysis Catheter Insertion
- First Posted Date
- 2019-10-30
- Last Posted Date
- 2021-08-25
- Lead Sponsor
- Hartford Hospital
- Target Recruit Count
- 14
- Registration Number
- NCT04144374
- Locations
- 🇺🇸
Hartford Hospital, Hartford, Connecticut, United States
Vaginal Probiotics and Pessaries and Their Impact on the Vaginal Microenvironment
Not Applicable
Completed
- Conditions
- Pelvic Organ ProlapseInflammatory ResponseDysbiosis
- Interventions
- Other: Standard CareOther: BiopHreshTM vaginal probiotic supplement (Good Clean Love, Inc. Eugene, OR) and RestoreTM gel.
- First Posted Date
- 2019-10-07
- Last Posted Date
- 2022-03-25
- Lead Sponsor
- Hartford Hospital
- Target Recruit Count
- 141
- Registration Number
- NCT04118049
- Locations
- 🇺🇸
Hartford Hospital, Hartford, Connecticut, United States
What is the Impact of the Presence of a Support Person on Informed Consent
Completed
- Conditions
- Knowledge, Attitudes, PracticeProlapse, VaginalUrinary IncontinenceSurgery
- Interventions
- Other: Preoperative support person presentOther: Patient Present Only
- First Posted Date
- 2019-05-29
- Last Posted Date
- 2020-04-07
- Lead Sponsor
- Hartford Hospital
- Target Recruit Count
- 82
- Registration Number
- NCT03966469
- Locations
- 🇺🇸
Hartford Hospital, Hartford, Connecticut, United States
LIBERATE - LIposomal Bupivacaine vERsus Adjuncts in Total shouldErs
Phase 4
Completed
- Conditions
- Pain ManagementPost-operative PainTotal Shoulder ArthroplastyOsteoarthritis of the Shoulder
- Interventions
- Drug: Liposomal Bupivicaine 1.3%
- First Posted Date
- 2019-03-25
- Last Posted Date
- 2023-09-15
- Lead Sponsor
- Hartford Hospital
- Target Recruit Count
- 90
- Registration Number
- NCT03887650
- Locations
- 🇺🇸
The Bone and Joint Institute at Hartford Hospital, Hartford, Connecticut, United States